fanta.bio Sample: CNhs11248
20930 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2121 / 15948 (13.3%) | 917 / 159480 (0.6%) | −324.0 | −324.0 | 23.13 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1017 / 15948 (6.4%) | 479 / 159480 (0.3%) | −324.0 | −324.0 | 21.23 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1625 / 15948 (10.2%) | 782 / 159480 (0.5%) | −324.0 | −324.0 | 20.78 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2293 / 15948 (14.4%) | 1165 / 159480 (0.7%) | −324.0 | −324.0 | 19.68 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2222 / 15948 (13.9%) | 1129 / 159480 (0.7%) | −324.0 | −324.0 | 19.68 |
| SCML2 SRX644728 | 293 Kidney | 1365 / 15948 (8.6%) | 723 / 159480 (0.5%) | −324.0 | −324.0 | 18.88 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1449 / 15948 (9.1%) | 810 / 159480 (0.5%) | −324.0 | −324.0 | 17.89 |
| FOXP1 SRX736067 | LNCAP Prostate | 1639 / 15948 (10.3%) | 1161 / 159480 (0.7%) | −324.0 | −324.0 | 14.12 |
| MYH11 SRX265221 | ME-1 Blood | 810 / 15948 (5.1%) | 635 / 159480 (0.4%) | −324.0 | −324.0 | 12.76 |
| MED1 SRX9419945 | BT-474 Breast | 2975 / 15948 (18.7%) | 2955 / 159480 (1.9%) | −324.0 | −324.0 | 10.07 |
| BRD4 SRX9419935 | BT-474 Breast | 2967 / 15948 (18.6%) | 2948 / 159480 (1.8%) | −324.0 | −324.0 | 10.06 |
| MED1 SRX9419944 | BT-474 Breast | 2882 / 15948 (18.1%) | 2906 / 159480 (1.8%) | −324.0 | −324.0 | 9.92 |
| BRD4 SRX9419936 | BT-474 Breast | 3011 / 15948 (18.9%) | 3093 / 159480 (1.9%) | −324.0 | −324.0 | 9.73 |
| MED1 SRX9419946 | BT-474 Breast | 3000 / 15948 (18.8%) | 3091 / 159480 (1.9%) | −324.0 | −324.0 | 9.71 |
| BRD4 SRX9419937 | BT-474 Breast | 2920 / 15948 (18.3%) | 3020 / 159480 (1.9%) | −324.0 | −324.0 | 9.67 |
| BRD4 SRX9419938 | BT-474 Breast | 2961 / 15948 (18.6%) | 3096 / 159480 (1.9%) | −324.0 | −324.0 | 9.56 |
| MED1 SRX9419947 | BT-474 Breast | 2907 / 15948 (18.2%) | 3042 / 159480 (1.9%) | −324.0 | −324.0 | 9.56 |
| EZH2 SRX2146136 | LNCAP Prostate | 6972 / 15948 (43.7%) | 7933 / 159480 (5.0%) | −324.0 | −324.0 | 8.79 |
| BRD4 SRX736201 | 90-8TL Neural | 5248 / 15948 (32.9%) | 6625 / 159480 (4.2%) | −324.0 | −324.0 | 7.92 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1634 / 15948 (10.2%) | 2653 / 159480 (1.7%) | −324.0 | −324.0 | 6.16 |
| TP53 SRX19538279 | Osteoblasts Bone | 474 / 15948 (3.0%) | 305 / 159480 (0.2%) | −283.7 | −280.5 | 15.54 |
| HIF1A SRX20663235 | HK-2 Kidney | 464 / 15948 (2.9%) | 287 / 159480 (0.2%) | −282.0 | −278.8 | 16.17 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1262 / 15948 (7.9%) | 3515 / 159480 (2.2%) | −274.3 | −271.2 | 3.59 |
| TP53 SRX19538274 | U2OS Bone | 393 / 15948 (2.5%) | 184 / 159480 (0.1%) | −263.2 | −260.0 | 21.36 |
| TP53 SRX19538268 | U2OS Bone | 390 / 15948 (2.4%) | 185 / 159480 (0.1%) | −260.1 | −257.0 | 21.08 |
| TP53 SRX19538276 | U2OS Bone | 389 / 15948 (2.4%) | 196 / 159480 (0.1%) | −254.3 | −251.2 | 19.85 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 628 / 15948 (3.9%) | 874 / 159480 (0.5%) | −252.1 | −249.0 | 7.19 |
| TP53 SRX19538280 | Osteoblasts Bone | 387 / 15948 (2.4%) | 213 / 159480 (0.1%) | −245.4 | −242.4 | 18.17 |
| TP53 SRX19538267 | U2OS Bone | 352 / 15948 (2.2%) | 168 / 159480 (0.1%) | −234.2 | −231.2 | 20.95 |
| TP53 SRX19538275 | U2OS Bone | 350 / 15948 (2.2%) | 186 / 159480 (0.1%) | −224.7 | −221.7 | 18.82 |
| TP53 SRX19538273 | U2OS Bone | 342 / 15948 (2.1%) | 177 / 159480 (0.1%) | −221.6 | −218.5 | 19.32 |
| TP53 SRX19538281 | Osteoblasts Bone | 397 / 15948 (2.5%) | 316 / 159480 (0.2%) | −217.0 | −214.0 | 12.56 |
| AGO2 SRX4708039 | Hep G2 Liver | 1722 / 15948 (10.8%) | 7113 / 159480 (4.5%) | −210.2 | −207.2 | 2.42 |
| TP53 SRX19538269 | U2OS Bone | 431 / 15948 (2.7%) | 439 / 159480 (0.3%) | −208.5 | −205.5 | 9.82 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 339 / 15948 (2.1%) | 234 / 159480 (0.1%) | −197.1 | −194.1 | 14.49 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 547 / 15948 (3.4%) | 913 / 159480 (0.6%) | −192.3 | −189.3 | 5.99 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 547 / 15948 (3.4%) | 970 / 159480 (0.6%) | −183.2 | −180.3 | 5.64 |
| TP53 SRX19538270 | U2OS Bone | 395 / 15948 (2.5%) | 436 / 159480 (0.3%) | −182.7 | −179.8 | 9.06 |
| IRF3 SRX11453858 | Hep G2 Liver | 248 / 15948 (1.6%) | 88 / 159480 (0.1%) | −180.0 | −177.1 | 28.18 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1297 / 15948 (8.1%) | 4949 / 159480 (3.1%) | −179.9 | −177.0 | 2.62 |
| BRD4 SRX736204 | 90-8TL Neural | 909 / 15948 (5.7%) | 2735 / 159480 (1.7%) | −177.7 | −174.8 | 3.32 |
| FOXA1 SRX176862 | MCF-7 Breast | 426 / 15948 (2.7%) | 13127 / 159480 (8.2%) | −176.5 | −173.6 | 0.32 |
| BRD1 SRX286203 | RKO Digestive tract | 1103 / 15948 (6.9%) | 3858 / 159480 (2.4%) | −174.9 | −172.1 | 2.86 |
| ESR1 SRX371469 | MCF-7 Breast | 341 / 15948 (2.1%) | 11575 / 159480 (7.3%) | −172.0 | −169.1 | 0.29 |
| FOXA1 SRX176863 | MCF-7 Breast | 397 / 15948 (2.5%) | 12477 / 159480 (7.8%) | −171.0 | −168.2 | 0.32 |
| TP53 SRX19538282 | Osteoblasts Bone | 339 / 15948 (2.1%) | 320 / 159480 (0.2%) | −170.7 | −167.8 | 10.59 |
| Epitope tags SRX10549776 | K-562 Blood | 1271 / 15948 (8.0%) | 4939 / 159480 (3.1%) | −170.6 | −167.8 | 2.57 |
| KAT7 SRX101303 | RKO Digestive tract | 1242 / 15948 (7.8%) | 4766 / 159480 (3.0%) | −170.2 | −167.3 | 2.61 |
| PBX4 SRX2731658 | PC-3 Prostate | 1275 / 15948 (8.0%) | 24803 / 159480 (15.6%) | −165.3 | −162.5 | 0.51 |
| BRPF3 SRX796085 | RKO Digestive tract | 984 / 15948 (6.2%) | 3327 / 159480 (2.1%) | −163.7 | −160.9 | 2.96 |
| BRPF3 SRX796084 | RKO Digestive tract | 1377 / 15948 (8.6%) | 5741 / 159480 (3.6%) | −163.2 | −160.4 | 2.40 |
| BRPF3 SRX796086 | RKO Digestive tract | 1324 / 15948 (8.3%) | 5407 / 159480 (3.4%) | −162.8 | −160.0 | 2.45 |
| ESR1 SRX176860 | MCF-7 Breast | 570 / 15948 (3.6%) | 14883 / 159480 (9.3%) | −162.4 | −159.6 | 0.38 |
| TP53 SRX19538271 | U2OS Bone | 569 / 15948 (3.6%) | 1214 / 159480 (0.8%) | −162.0 | −159.2 | 4.69 |
| ESR1 SRX4367193 | MCF-7 Breast | 1110 / 15948 (7.0%) | 22449 / 159480 (14.1%) | −161.2 | −158.5 | 0.49 |
| FOXA1 SRX371483 | MCF-7 Breast | 393 / 15948 (2.5%) | 12047 / 159480 (7.6%) | −160.1 | −157.4 | 0.33 |
| FOXA1 SRX371481 | MCF-7 Breast | 367 / 15948 (2.3%) | 11618 / 159480 (7.3%) | −160.1 | −157.3 | 0.32 |
| ESR1 SRX7624157 | MCF-7 Breast | 898 / 15948 (5.6%) | 19499 / 159480 (12.2%) | −159.6 | −156.8 | 0.46 |
| ESR1 SRX176861 | MCF-7 Breast | 582 / 15948 (3.6%) | 14920 / 159480 (9.4%) | −158.4 | −155.6 | 0.39 |
| ESR1 SRX371478 | MCF-7 Breast | 456 / 15948 (2.9%) | 12988 / 159480 (8.1%) | −158.3 | −155.6 | 0.35 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1141 / 15948 (7.2%) | 22711 / 159480 (14.2%) | −157.7 | −154.9 | 0.50 |
| ESR1 SRX20282961 | MCF-7 Breast | 451 / 15948 (2.8%) | 12872 / 159480 (8.1%) | −157.2 | −154.5 | 0.35 |
| FOXA1 SRX1161177 | MCF-7 Breast | 363 / 15948 (2.3%) | 11388 / 159480 (7.1%) | −155.1 | −152.4 | 0.32 |
| ESR1 SRX371468 | MCF-7 Breast | 217 / 15948 (1.4%) | 8862 / 159480 (5.6%) | −154.8 | −152.0 | 0.24 |
| ESR1 SRX194572 | MCF-7 Breast | 217 / 15948 (1.4%) | 8859 / 159480 (5.6%) | −154.6 | −151.9 | 0.24 |
| AGO2 SRX6783958 | Hep G2 Liver | 1103 / 15948 (6.9%) | 4169 / 159480 (2.6%) | −154.4 | −151.7 | 2.65 |
| ESR1 SRX371467 | MCF-7 Breast | 376 / 15948 (2.4%) | 11549 / 159480 (7.2%) | −153.7 | −151.0 | 0.33 |
| FOXA1 SRX4815197 | MCF-7 Breast | 852 / 15948 (5.3%) | 18604 / 159480 (11.7%) | −153.3 | −150.6 | 0.46 |
| AGO2 SRX6783957 | Hep G2 Liver | 1116 / 15948 (7.0%) | 4287 / 159480 (2.7%) | −152.0 | −149.3 | 2.60 |
| ESR1 SRX20282960 | MCF-7 Breast | 416 / 15948 (2.6%) | 12133 / 159480 (7.6%) | −152.0 | −149.3 | 0.34 |
| ESR1 SRX10365536 | MCF-7 Breast | 179 / 15948 (1.1%) | 8046 / 159480 (5.0%) | −151.2 | −148.5 | 0.22 |
| ESR1 SRX20282939 | MCF-7 Breast | 412 / 15948 (2.6%) | 12033 / 159480 (7.5%) | −150.9 | −148.2 | 0.34 |
| ESR1 SRX1531791 | MCF-7 Breast | 349 / 15948 (2.2%) | 11001 / 159480 (6.9%) | −150.5 | −147.8 | 0.32 |
| IRF3 SRX11453861 | Hep G2 Liver | 214 / 15948 (1.3%) | 86 / 159480 (0.1%) | −150.2 | −147.5 | 24.88 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 566 / 15948 (3.5%) | 1305 / 159480 (0.8%) | −149.3 | −146.7 | 4.34 |
| ESR1 SRX194569 | MCF-7 Breast | 383 / 15948 (2.4%) | 11516 / 159480 (7.2%) | −149.3 | −146.7 | 0.33 |
| FOXA1 SRX1161176 | MCF-7 Breast | 350 / 15948 (2.2%) | 10964 / 159480 (6.9%) | −148.9 | −146.3 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 584 / 15948 (3.7%) | 14565 / 159480 (9.1%) | −148.1 | −145.4 | 0.40 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 855 / 15948 (5.4%) | 2819 / 159480 (1.8%) | −147.2 | −144.6 | 3.03 |
| ESR1 SRX371479 | MCF-7 Breast | 347 / 15948 (2.2%) | 10804 / 159480 (6.8%) | −145.6 | −143.0 | 0.32 |
| ING5 SRX286202 | RKO Digestive tract | 1188 / 15948 (7.4%) | 4872 / 159480 (3.1%) | −144.4 | −141.8 | 2.44 |
| AR SRX10820653 | LNCAP Prostate | 263 / 15948 (1.6%) | 210 / 159480 (0.1%) | −143.6 | −141.0 | 12.52 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 227 / 15948 (1.4%) | 127 / 159480 (0.1%) | −143.2 | −140.6 | 17.87 |
| TP53 SRX396254 | Fibroblasts Others | 800 / 15948 (5.0%) | 2570 / 159480 (1.6%) | −142.8 | −140.2 | 3.11 |
| ESR1 SRX20282972 | MCF-7 Breast | 418 / 15948 (2.6%) | 11847 / 159480 (7.4%) | −142.7 | −140.2 | 0.35 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 799 / 15948 (5.0%) | 2566 / 159480 (1.6%) | −142.6 | −140.1 | 3.11 |
| ESR1 SRX371471 | ZR-75-1 Breast | 406 / 15948 (2.5%) | 11649 / 159480 (7.3%) | −142.5 | −139.9 | 0.35 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 442 / 15948 (2.8%) | 12196 / 159480 (7.6%) | −142.1 | −139.6 | 0.36 |
| ESR1 SRX371470 | ZR-75-1 Breast | 343 / 15948 (2.2%) | 10585 / 159480 (6.6%) | −140.9 | −138.4 | 0.32 |
| ESR1 SRX371476 | MCF-7 Breast | 283 / 15948 (1.8%) | 9551 / 159480 (6.0%) | −139.9 | −137.4 | 0.30 |
| FOXA1 SRX371482 | MCF-7 Breast | 541 / 15948 (3.4%) | 13623 / 159480 (8.5%) | −139.9 | −137.3 | 0.40 |
| FOXA1 SRX1161173 | MCF-7 Breast | 305 / 15948 (1.9%) | 9921 / 159480 (6.2%) | −139.9 | −137.3 | 0.31 |
| ESR1 SRX10365535 | MCF-7 Breast | 303 / 15948 (1.9%) | 9874 / 159480 (6.2%) | −139.5 | −137.0 | 0.31 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 565 / 15948 (3.5%) | 1394 / 159480 (0.9%) | −138.9 | −136.3 | 4.05 |
| ESR1 SRX20282954 | MCF-7 Breast | 420 / 15948 (2.6%) | 11716 / 159480 (7.3%) | −138.2 | −135.7 | 0.36 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1033 / 15948 (6.5%) | 4016 / 159480 (2.5%) | −137.5 | −135.0 | 2.57 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 451 / 15948 (2.8%) | 12147 / 159480 (7.6%) | −136.9 | −134.4 | 0.37 |
| ESR1 SRX330069 | MCF-7 Breast | 224 / 15948 (1.4%) | 8427 / 159480 (5.3%) | −136.8 | −134.2 | 0.27 |
| GATA3 SRX176864 | MCF-7 Breast | 287 / 15948 (1.8%) | 9458 / 159480 (5.9%) | −135.0 | −132.5 | 0.30 |
| FOXA1 SRX1161175 | MCF-7 Breast | 293 / 15948 (1.8%) | 9555 / 159480 (6.0%) | −134.8 | −132.3 | 0.31 |
| ESR1 SRX2943591 | MCF-7 Breast | 263 / 15948 (1.6%) | 9043 / 159480 (5.7%) | −134.8 | −132.3 | 0.29 |
| LARP7 SRX2198835 | HeLa Uterus | 1920 / 15948 (12.0%) | 10186 / 159480 (6.4%) | −134.3 | −131.8 | 1.88 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 306 / 15948 (1.9%) | 9702 / 159480 (6.1%) | −132.9 | −130.4 | 0.32 |
| FOS SRX150477 | MCF 10A Breast | 917 / 15948 (5.7%) | 18646 / 159480 (11.7%) | −132.8 | −130.3 | 0.49 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 384 / 15948 (2.4%) | 655 / 159480 (0.4%) | −132.5 | −130.0 | 5.86 |
| ESR1 SRX330070 | MCF-7 Breast | 193 / 15948 (1.2%) | 7724 / 159480 (4.8%) | −132.1 | −129.6 | 0.25 |
| GATA3 SRX5057632 | MCF-7 Breast | 262 / 15948 (1.6%) | 8920 / 159480 (5.6%) | −131.5 | −129.1 | 0.29 |
| ESR1 SRX10365558 | MCF-7 Breast | 257 / 15948 (1.6%) | 8831 / 159480 (5.5%) | −131.4 | −128.9 | 0.29 |
| ESR1 SRX20282955 | MCF-7 Breast | 416 / 15948 (2.6%) | 11405 / 159480 (7.2%) | −131.3 | −128.8 | 0.36 |
| RAC1 SRX10365543 | MCF-7 Breast | 212 / 15948 (1.3%) | 8043 / 159480 (5.0%) | −131.3 | −128.8 | 0.26 |
| ESR1 SRX10365532 | MCF-7 Breast | 208 / 15948 (1.3%) | 7970 / 159480 (5.0%) | −131.2 | −128.7 | 0.26 |
| CDK9 SRX7366783 | MCF-7 Breast | 221 / 15948 (1.4%) | 146 / 159480 (0.1%) | −130.9 | −128.5 | 15.14 |
| ESR1 SRX330067 | MCF-7 Breast | 353 / 15948 (2.2%) | 10398 / 159480 (6.5%) | −130.9 | −128.4 | 0.34 |
| LEO1 SRX1873456 | SEM Blood | 1286 / 15948 (8.1%) | 5778 / 159480 (3.6%) | −130.8 | −128.4 | 2.23 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 763 / 15948 (4.8%) | 2524 / 159480 (1.6%) | −130.5 | −128.0 | 3.02 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1191 / 15948 (7.5%) | 5176 / 159480 (3.2%) | −129.4 | −127.0 | 2.30 |
| GATA3 SRX190239 | MCF-7 Breast | 583 / 15948 (3.7%) | 13818 / 159480 (8.7%) | −128.9 | −126.4 | 0.42 |
| FOXA1 SRX371480 | MCF-7 Breast | 270 / 15948 (1.7%) | 8965 / 159480 (5.6%) | −128.7 | −126.3 | 0.30 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 672 / 15948 (4.2%) | 15089 / 159480 (9.5%) | −128.7 | −126.2 | 0.45 |
| ESR1 SRX371477 | MCF-7 Breast | 193 / 15948 (1.2%) | 7612 / 159480 (4.8%) | −128.4 | −126.0 | 0.25 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 705 / 15948 (4.4%) | 2233 / 159480 (1.4%) | −128.1 | −125.6 | 3.16 |
| FOXA1 SRX11222437 | MCF-7 Breast | 282 / 15948 (1.8%) | 9142 / 159480 (5.7%) | −128.0 | −125.6 | 0.31 |
| FOXA1 SRX3931044 | MCF-7 Breast | 830 / 15948 (5.2%) | 17244 / 159480 (10.8%) | −127.6 | −125.2 | 0.48 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 572 / 15948 (3.6%) | 13596 / 159480 (8.5%) | −127.2 | −124.8 | 0.42 |
| ESR1 SRX3123829 | MCF-7 Breast | 224 / 15948 (1.4%) | 8122 / 159480 (5.1%) | −127.2 | −124.8 | 0.28 |
| FOXA1 SRX028635 | MCF-7 Breast | 192 / 15948 (1.2%) | 7554 / 159480 (4.7%) | −127.2 | −124.8 | 0.25 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 773 / 15948 (4.8%) | 2642 / 159480 (1.7%) | −126.0 | −123.6 | 2.93 |
| FOXA1 SRX1787653 | MCF-7 Breast | 329 / 15948 (2.1%) | 9817 / 159480 (6.2%) | −125.3 | −122.9 | 0.34 |
| ESR1 SRX20282973 | MCF-7 Breast | 485 / 15948 (3.0%) | 12222 / 159480 (7.7%) | −124.9 | −122.5 | 0.40 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 371 / 15948 (2.3%) | 10475 / 159480 (6.6%) | −124.9 | −122.5 | 0.35 |
| TLE3 SRX4815191 | MCF-7 Breast | 402 / 15948 (2.5%) | 10946 / 159480 (6.9%) | −124.6 | −122.2 | 0.37 |
| ESR1 SRX2912055 | MCF-7 Breast | 150 / 15948 (0.9%) | 6696 / 159480 (4.2%) | −124.5 | −122.1 | 0.22 |
| ESR1 SRX2881002 | MCF-7 Breast | 381 / 15948 (2.4%) | 10602 / 159480 (6.6%) | −124.1 | −121.7 | 0.36 |
| FOS SRX150478 | MCF 10A Breast | 980 / 15948 (6.1%) | 19092 / 159480 (12.0%) | −123.8 | −121.4 | 0.51 |
| EP300 SRX1012648 | MCF-7 Breast | 190 / 15948 (1.2%) | 7408 / 159480 (4.6%) | −123.6 | −121.3 | 0.26 |
| ESR1 SRX4367192 | MCF-7 Breast | 805 / 15948 (5.0%) | 16694 / 159480 (10.5%) | −122.8 | −120.4 | 0.48 |
| MEAF6 DRX234811 | 293 Kidney | 1442 / 15948 (9.0%) | 7032 / 159480 (4.4%) | −122.8 | −120.4 | 2.05 |
| Epitope tags DRX443510 | 293 Kidney | 1258 / 15948 (7.9%) | 5761 / 159480 (3.6%) | −122.7 | −120.4 | 2.18 |
| ESR1 SRX20282946 | MCF-7 Breast | 247 / 15948 (1.5%) | 8371 / 159480 (5.2%) | −122.6 | −120.2 | 0.30 |
| ESR1 SRX2943589 | MCF-7 Breast | 204 / 15948 (1.3%) | 7603 / 159480 (4.8%) | −122.0 | −119.6 | 0.27 |
| SSRP1 SRX3436563 | HT-1080 Bone | 768 / 15948 (4.8%) | 2671 / 159480 (1.7%) | −121.9 | −119.6 | 2.88 |
| ESR1 SRX2881000 | MCF-7 Breast | 359 / 15948 (2.3%) | 10176 / 159480 (6.4%) | −121.9 | −119.5 | 0.35 |
| ESR1 SRX371475 | BT-474 Breast | 207 / 15948 (1.3%) | 7652 / 159480 (4.8%) | −121.8 | −119.5 | 0.27 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 377 / 15948 (2.4%) | 10451 / 159480 (6.6%) | −121.6 | −119.2 | 0.36 |
| RAC1 SRX10365541 | MCF-7 Breast | 229 / 15948 (1.4%) | 8009 / 159480 (5.0%) | −121.0 | −118.6 | 0.29 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 371 / 15948 (2.3%) | 10327 / 159480 (6.5%) | −120.8 | −118.5 | 0.36 |
| AR SRX1067071 | LHSAR Prostate | 777 / 15948 (4.9%) | 16211 / 159480 (10.2%) | −120.5 | −118.2 | 0.48 |
| 8-Hydroxydeoxyguanosine SRX13840522 | MCF 10A Breast | 1083 / 15948 (6.8%) | 4656 / 159480 (2.9%) | −119.8 | −117.4 | 2.33 |
| FOXA1 SRX11222441 | MCF-7 Breast | 319 / 15948 (2.0%) | 9457 / 159480 (5.9%) | −119.6 | −117.2 | 0.34 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 1461 / 15948 (9.2%) | 7243 / 159480 (4.5%) | −119.6 | −117.2 | 2.02 |
| 8-Hydroxydeoxyguanosine SRX13840520 | MCF 10A Breast | 776 / 15948 (4.9%) | 2750 / 159480 (1.7%) | −119.5 | −117.2 | 2.82 |
| ESR1 SRX1012632 | MCF-7 Breast | 205 / 15948 (1.3%) | 7536 / 159480 (4.7%) | −119.3 | −117.0 | 0.27 |
| Epitope tags SRX10549778 | K-562 Blood | 964 / 15948 (6.0%) | 3902 / 159480 (2.4%) | −119.3 | −116.9 | 2.47 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 604 / 15948 (3.8%) | 13727 / 159480 (8.6%) | −119.0 | −116.7 | 0.44 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 381 / 15948 (2.4%) | 734 / 159480 (0.5%) | −118.9 | −116.6 | 5.19 |
| PGR SRX1012655 | MCF-7 Breast | 268 / 15948 (1.7%) | 8591 / 159480 (5.4%) | −118.6 | −116.3 | 0.31 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 408 / 15948 (2.6%) | 10821 / 159480 (6.8%) | −118.6 | −116.3 | 0.38 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 663 / 15948 (4.2%) | 2122 / 159480 (1.3%) | −118.6 | −116.3 | 3.12 |
| ESR1 SRX1469949 | MCF-7 Breast | 236 / 15948 (1.5%) | 8045 / 159480 (5.0%) | −118.5 | −116.2 | 0.29 |
| FOXA1 SRX1787651 | MCF-7 Breast | 232 / 15948 (1.5%) | 7981 / 159480 (5.0%) | −118.5 | −116.1 | 0.29 |
| FOXA1 SRX5323843 | MCF-7 Breast | 215 / 15948 (1.3%) | 7674 / 159480 (4.8%) | −118.2 | −115.9 | 0.28 |
| FOXA1 SRX3923514 | MCF-7 Breast | 424 / 15948 (2.7%) | 11048 / 159480 (6.9%) | −118.1 | −115.8 | 0.38 |
| ESR1 SRX371474 | BT-474 Breast | 194 / 15948 (1.2%) | 7302 / 159480 (4.6%) | −118.0 | −115.7 | 0.27 |
| FOXA1 SRX1787655 | MCF-7 Breast | 207 / 15948 (1.3%) | 7527 / 159480 (4.7%) | −118.0 | −115.7 | 0.28 |
| FOXA1 SRX028634 | MCF-7 Breast | 205 / 15948 (1.3%) | 7491 / 159480 (4.7%) | −117.9 | −115.6 | 0.27 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 461 / 15948 (2.9%) | 1098 / 159480 (0.7%) | −117.5 | −115.2 | 4.20 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 325 / 15948 (2.0%) | 9485 / 159480 (5.9%) | −117.5 | −115.2 | 0.34 |
| ESR1 SRX1012629 | MCF-7 Breast | 264 / 15948 (1.7%) | 8488 / 159480 (5.3%) | −117.5 | −115.2 | 0.31 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 295 / 15948 (1.8%) | 8992 / 159480 (5.6%) | −117.3 | −115.0 | 0.33 |
| AR SRX10820651 | LNCAP Prostate | 265 / 15948 (1.7%) | 316 / 159480 (0.2%) | −117.2 | −114.9 | 8.39 |
| CDK9 SRX7366781 | MCF-7 Breast | 203 / 15948 (1.3%) | 143 / 159480 (0.1%) | −117.2 | −114.9 | 14.20 |
| KMT2A SRX2323891 | 293 Kidney | 859 / 15948 (5.4%) | 3286 / 159480 (2.1%) | −117.1 | −114.8 | 2.61 |
| ESR1 SRX10365533 | MCF-7 Breast | 204 / 15948 (1.3%) | 7437 / 159480 (4.7%) | −116.8 | −114.5 | 0.27 |
| ESR1 SRX20282940 | MCF-7 Breast | 455 / 15948 (2.9%) | 11462 / 159480 (7.2%) | −116.8 | −114.5 | 0.40 |
| ESR1 SRX3110725 | MCF-7 Breast | 373 / 15948 (2.3%) | 10213 / 159480 (6.4%) | −116.8 | −114.5 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 439 / 15948 (2.8%) | 11213 / 159480 (7.0%) | −116.5 | −114.3 | 0.39 |
| ESR1 SRX20282953 | MCF-7 Breast | 347 / 15948 (2.2%) | 9794 / 159480 (6.1%) | −116.5 | −114.2 | 0.35 |
| FOXA1 SRX11222438 | MCF-7 Breast | 224 / 15948 (1.4%) | 7774 / 159480 (4.9%) | −116.4 | −114.1 | 0.29 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 869 / 15948 (5.4%) | 17265 / 159480 (10.8%) | −116.0 | −113.7 | 0.50 |
| TLE3 SRX4815192 | MCF-7 Breast | 376 / 15948 (2.4%) | 10196 / 159480 (6.4%) | −115.1 | −112.8 | 0.37 |
| ESR1 SRX20282971 | MCF-7 Breast | 422 / 15948 (2.6%) | 10889 / 159480 (6.8%) | −114.7 | −112.4 | 0.39 |
| TP53 SRX19538272 | U2OS Bone | 461 / 15948 (2.9%) | 1127 / 159480 (0.7%) | −114.3 | −112.1 | 4.09 |
| ESR1 SRX1012633 | MCF-7 Breast | 221 / 15948 (1.4%) | 7650 / 159480 (4.8%) | −114.2 | −112.0 | 0.29 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 692 / 15948 (4.3%) | 2348 / 159480 (1.5%) | −113.8 | −111.6 | 2.95 |
| FOXA1 SRX1787652 | MCF-7 Breast | 263 / 15948 (1.6%) | 8345 / 159480 (5.2%) | −113.8 | −111.6 | 0.32 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 545 / 15948 (3.4%) | 12658 / 159480 (7.9%) | −113.5 | −111.2 | 0.43 |
| FOXA1 SRX11222442 | MCF-7 Breast | 289 / 15948 (1.8%) | 8761 / 159480 (5.5%) | −113.5 | −111.2 | 0.33 |
| SSRP1 SRX3436567 | HT-1080 Bone | 324 / 15948 (2.0%) | 543 / 159480 (0.3%) | −113.4 | −111.2 | 5.97 |
| FOXA2 SRX100448 | Hep G2 Liver | 466 / 15948 (2.9%) | 11498 / 159480 (7.2%) | −113.3 | −111.1 | 0.41 |
| KAT6A SRX20971022 | Fibroblasts Others | 185 / 15948 (1.2%) | 113 / 159480 (0.1%) | −113.1 | −110.9 | 16.37 |
| 8-Hydroxydeoxyguanosine SRX2935293 | MCF 10A Breast | 490 / 15948 (3.1%) | 1279 / 159480 (0.8%) | −113.1 | −110.8 | 3.83 |
| FOXA1 SRX100506 | Hep G2 Liver | 557 / 15948 (3.5%) | 12798 / 159480 (8.0%) | −112.6 | −110.4 | 0.44 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 566 / 15948 (3.5%) | 1674 / 159480 (1.0%) | −112.4 | −110.2 | 3.38 |
| ESR1 SRX4451212 | MCF-7 Breast | 403 / 15948 (2.5%) | 10512 / 159480 (6.6%) | −112.3 | −110.1 | 0.38 |
| MEAF6 DRX300417 | 293 Kidney | 1292 / 15948 (8.1%) | 6235 / 159480 (3.9%) | −112.2 | −109.9 | 2.07 |
| GFP SRX12567758 | MRC-5 Lung | 1298 / 15948 (8.1%) | 6279 / 159480 (3.9%) | −112.1 | −109.8 | 2.07 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 215 / 15948 (1.3%) | 7478 / 159480 (4.7%) | −112.1 | −109.8 | 0.29 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1620 / 15948 (10.2%) | 8595 / 159480 (5.4%) | −111.9 | −109.7 | 1.88 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 430 / 15948 (2.7%) | 10902 / 159480 (6.8%) | −111.9 | −109.7 | 0.39 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 345 / 15948 (2.2%) | 9585 / 159480 (6.0%) | −111.5 | −109.3 | 0.36 |
| BMI1 SRX644729 | 293 Kidney | 194 / 15948 (1.2%) | 139 / 159480 (0.1%) | −111.2 | −109.0 | 13.96 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 683 / 15948 (4.3%) | 14504 / 159480 (9.1%) | −110.8 | −108.6 | 0.47 |
| ESR1 SRX4451213 | MCF-7 Breast | 438 / 15948 (2.7%) | 10981 / 159480 (6.9%) | −110.7 | −108.5 | 0.40 |
| CEBPA SRX2630241 | Hep G2 Liver | 515 / 15948 (3.2%) | 12106 / 159480 (7.6%) | −110.4 | −108.2 | 0.43 |
| FOXA2 SRX3230382 | Hep G2 Liver | 577 / 15948 (3.6%) | 12988 / 159480 (8.1%) | −110.2 | −108.0 | 0.44 |
| ING2 SRX286201 | RKO Digestive tract | 1199 / 15948 (7.5%) | 5647 / 159480 (3.5%) | −109.7 | −107.5 | 2.12 |
| NFYB SRX16608147 | HeLa Uterus | 212 / 15948 (1.3%) | 190 / 159480 (0.1%) | −109.7 | −107.5 | 11.16 |
| ESR1 SRX1012630 | MCF-7 Breast | 173 / 15948 (1.1%) | 6658 / 159480 (4.2%) | −109.5 | −107.3 | 0.26 |
| FOXA1 SRX3931043 | MCF-7 Breast | 443 / 15948 (2.8%) | 11006 / 159480 (6.9%) | −109.4 | −107.2 | 0.40 |
| ESR1 SRX11120903 | MCF-7 Breast | 379 / 15948 (2.4%) | 10035 / 159480 (6.3%) | −109.4 | −107.2 | 0.38 |
| EP300 SRX1012644 | MCF-7 Breast | 204 / 15948 (1.3%) | 7199 / 159480 (4.5%) | −109.4 | −107.2 | 0.28 |
| ESR1 SRX20282938 | MCF-7 Breast | 354 / 15948 (2.2%) | 9644 / 159480 (6.0%) | −109.3 | −107.1 | 0.37 |
| ESR1 SRX330068 | MCF-7 Breast | 213 / 15948 (1.3%) | 7349 / 159480 (4.6%) | −109.2 | −107.0 | 0.29 |
| GATA3 SRX6712581 | MCF-7 Breast | 357 / 15948 (2.2%) | 9681 / 159480 (6.1%) | −109.0 | −106.9 | 0.37 |
| FOXA1 SRX100454 | T-47D Breast | 558 / 15948 (3.5%) | 12662 / 159480 (7.9%) | −108.9 | −106.8 | 0.44 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 622 / 15948 (3.9%) | 2020 / 159480 (1.3%) | −108.9 | −106.8 | 3.08 |
| ESR1 SRX1531796 | MCF-7 Breast | 240 / 15948 (1.5%) | 7779 / 159480 (4.9%) | −108.3 | −106.1 | 0.31 |
| ESR1 SRX20282959 | MCF-7 Breast | 188 / 15948 (1.2%) | 6876 / 159480 (4.3%) | −108.0 | −105.8 | 0.27 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1037 / 15948 (6.5%) | 4590 / 159480 (2.9%) | −108.0 | −105.8 | 2.26 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 396 / 15948 (2.5%) | 10236 / 159480 (6.4%) | −107.8 | −105.6 | 0.39 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 410 / 15948 (2.6%) | 948 / 159480 (0.6%) | −107.7 | −105.6 | 4.32 |
| ESR1 SRX3110723 | MCF-7 Breast | 246 / 15948 (1.5%) | 7852 / 159480 (4.9%) | −107.6 | −105.5 | 0.31 |
| ESR1 SRX176856 | MCF-7 Breast | 156 / 15948 (1.0%) | 6286 / 159480 (3.9%) | −107.6 | −105.4 | 0.25 |
| ESR1 SRX8537722 | MCF-7 Breast | 407 / 15948 (2.6%) | 10393 / 159480 (6.5%) | −107.5 | −105.4 | 0.39 |
| FOXA1 SRX3923517 | MCF-7 Breast | 315 / 15948 (2.0%) | 8966 / 159480 (5.6%) | −107.5 | −105.3 | 0.35 |
| FOXA1 SRX3931055 | MCF-7 Breast | 376 / 15948 (2.4%) | 9913 / 159480 (6.2%) | −107.4 | −105.2 | 0.38 |
| FOXA1 SRX5203303 | MCF-7 Breast | 154 / 15948 (1.0%) | 6241 / 159480 (3.9%) | −107.3 | −105.1 | 0.25 |
| ESR1 SRX1995230 | MCF-7 Breast | 370 / 15948 (2.3%) | 9815 / 159480 (6.2%) | −107.2 | −105.0 | 0.38 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 226 / 15948 (1.4%) | 7498 / 159480 (4.7%) | −107.1 | −104.9 | 0.30 |
| ESR1 SRX1469951 | MCF-7 Breast | 233 / 15948 (1.5%) | 7597 / 159480 (4.8%) | −106.4 | −104.3 | 0.31 |
| FOXA1 SRX5323845 | MCF-7 Breast | 168 / 15948 (1.1%) | 6463 / 159480 (4.1%) | −106.2 | −104.1 | 0.26 |
| FOXA1 SRX3923516 | MCF-7 Breast | 320 / 15948 (2.0%) | 8998 / 159480 (5.6%) | −106.2 | −104.0 | 0.36 |
| EP300 SRX176883 | MCF-7 Breast | 214 / 15948 (1.3%) | 7264 / 159480 (4.6%) | −106.1 | −103.9 | 0.29 |
| ARID1A SRX5089376 | MCF-7 Breast | 395 / 15948 (2.5%) | 10155 / 159480 (6.4%) | −106.0 | −103.9 | 0.39 |
| ESR1 SRX3110720 | MCF-7 Breast | 190 / 15948 (1.2%) | 6838 / 159480 (4.3%) | −105.8 | −103.6 | 0.28 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 168 / 15948 (1.1%) | 95 / 159480 (0.1%) | −105.8 | −103.6 | 17.68 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 164 / 15948 (1.0%) | 87 / 159480 (0.1%) | −105.6 | −103.5 | 18.85 |
| FOXA1 SRX1447316 | MCF-7 Breast | 190 / 15948 (1.2%) | 6825 / 159480 (4.3%) | −105.4 | −103.2 | 0.28 |
| ESR1 SRX2513520 | MCF-7 Breast | 283 / 15948 (1.8%) | 8382 / 159480 (5.3%) | −105.4 | −103.2 | 0.34 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 933 / 15948 (5.9%) | 17625 / 159480 (11.1%) | −105.3 | −103.2 | 0.53 |
| ESR1 SRX5323871 | MCF-7 Breast | 482 / 15948 (3.0%) | 11418 / 159480 (7.2%) | −105.3 | −103.2 | 0.42 |
| FOXA1 SRX3923518 | MCF-7 Breast | 310 / 15948 (1.9%) | 8800 / 159480 (5.5%) | −105.0 | −102.9 | 0.35 |
| EP300 SRX176885 | MCF-7 Breast | 240 / 15948 (1.5%) | 7658 / 159480 (4.8%) | −104.7 | −102.6 | 0.31 |
| EP300 SRX1012643 | MCF-7 Breast | 170 / 15948 (1.1%) | 6439 / 159480 (4.0%) | −104.4 | −102.3 | 0.26 |
| ESR1 SRX2881001 | MCF-7 Breast | 255 / 15948 (1.6%) | 7890 / 159480 (4.9%) | −104.3 | −102.2 | 0.32 |
| FOXA1 SRX3931054 | MCF-7 Breast | 418 / 15948 (2.6%) | 10429 / 159480 (6.5%) | −104.2 | −102.1 | 0.40 |
| FOXA1 SRX5203307 | MCF-7 Breast | 137 / 15948 (0.9%) | 5822 / 159480 (3.7%) | −104.0 | −101.9 | 0.24 |
| ESR1 SRX3123823 | MCF-7 Breast | 162 / 15948 (1.0%) | 6283 / 159480 (3.9%) | −104.0 | −101.9 | 0.26 |
| STAT5B SRX831881 | CD8+ T cells Blood | 191 / 15948 (1.2%) | 154 / 159480 (0.1%) | −104.0 | −101.9 | 12.40 |
| FOS SRX4192880 | MCF 10A Breast | 750 / 15948 (4.7%) | 15120 / 159480 (9.5%) | −103.9 | −101.8 | 0.50 |
| AR SRX9469988 | LAPC-4 Prostate | 577 / 15948 (3.6%) | 12724 / 159480 (8.0%) | −103.9 | −101.7 | 0.45 |
| ESR1 SRX2513517 | MCF-7 Breast | 310 / 15948 (1.9%) | 8753 / 159480 (5.5%) | −103.7 | −101.6 | 0.35 |
| NR3C1 SRX19024866 | MCF-7 Breast | 165 / 15948 (1.0%) | 6328 / 159480 (4.0%) | −103.7 | −101.6 | 0.26 |
| ESR1 SRX1995229 | MCF-7 Breast | 442 / 15948 (2.8%) | 10765 / 159480 (6.8%) | −103.6 | −101.5 | 0.41 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 323 / 15948 (2.0%) | 8943 / 159480 (5.6%) | −103.3 | −101.2 | 0.36 |
| FOXA1 SRX1447317 | MCF-7 Breast | 294 / 15948 (1.8%) | 8484 / 159480 (5.3%) | −103.3 | −101.2 | 0.35 |
| ESR1 SRX10365534 | MCF-7 Breast | 144 / 15948 (0.9%) | 5928 / 159480 (3.7%) | −103.2 | −101.1 | 0.24 |
| FOXA1 SRX3923519 | MCF-7 Breast | 280 / 15948 (1.8%) | 8251 / 159480 (5.2%) | −103.0 | −100.9 | 0.34 |
| ESR1 SRX4451214 | MCF-7 Breast | 394 / 15948 (2.5%) | 10006 / 159480 (6.3%) | −102.5 | −100.4 | 0.39 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 432 / 15948 (2.7%) | 10550 / 159480 (6.6%) | −102.0 | −99.9 | 0.41 |
| AR SRX9109110 | MDA-MB-453 Breast | 797 / 15948 (5.0%) | 15653 / 159480 (9.8%) | −101.7 | −99.6 | 0.51 |
| FOXA1 SRX5203294 | MCF-7 Breast | 138 / 15948 (0.9%) | 5766 / 159480 (3.6%) | −101.6 | −99.5 | 0.24 |
| FOXA1 SRX3923515 | MCF-7 Breast | 261 / 15948 (1.6%) | 7871 / 159480 (4.9%) | −101.0 | −98.9 | 0.33 |
| NCOA3 SRX4663589 | MCF-7 Breast | 133 / 15948 (0.8%) | 5655 / 159480 (3.5%) | −100.9 | −98.8 | 0.24 |
| ESR1 SRX1012625 | MCF-7 Breast | 248 / 15948 (1.6%) | 7654 / 159480 (4.8%) | −100.8 | −98.7 | 0.32 |
| ESR1 SRX5323877 | MCF-7 Breast | 361 / 15948 (2.3%) | 9432 / 159480 (5.9%) | −100.6 | −98.5 | 0.38 |
| CEBPB SRX190345 | MCF-7 Breast | 353 / 15948 (2.2%) | 9306 / 159480 (5.8%) | −100.6 | −98.5 | 0.38 |
| ESR1 SRX2513521 | MCF-7 Breast | 227 / 15948 (1.4%) | 7295 / 159480 (4.6%) | −100.6 | −98.5 | 0.31 |
| ESR1 SRX5287697 | MCF-7 Breast | 177 / 15948 (1.1%) | 6432 / 159480 (4.0%) | −100.3 | −98.2 | 0.28 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 421 / 15948 (2.6%) | 10322 / 159480 (6.5%) | −100.3 | −98.2 | 0.41 |
| ESR1 SRX1012628 | MCF-7 Breast | 245 / 15948 (1.5%) | 7582 / 159480 (4.8%) | −100.2 | −98.1 | 0.32 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1116 / 15948 (7.0%) | 5297 / 159480 (3.3%) | −100.1 | −98.0 | 2.11 |
| NR3C1 SRX19024870 | MCF-7 Breast | 166 / 15948 (1.0%) | 6228 / 159480 (3.9%) | −100.0 | −98.0 | 0.27 |
| FOXA1 SRX3923511 | MCF-7 Breast | 182 / 15948 (1.1%) | 6498 / 159480 (4.1%) | −99.7 | −97.6 | 0.28 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 486 / 15948 (3.0%) | 11251 / 159480 (7.1%) | −99.6 | −97.6 | 0.43 |
| ESR1 SRX5323873 | MCF-7 Breast | 555 / 15948 (3.5%) | 12235 / 159480 (7.7%) | −99.6 | −97.5 | 0.45 |
| ESR1 SRX8537723 | MCF-7 Breast | 373 / 15948 (2.3%) | 9570 / 159480 (6.0%) | −99.5 | −97.4 | 0.39 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 139 / 15948 (0.9%) | 5712 / 159480 (3.6%) | −99.2 | −97.1 | 0.24 |
| RUNX1 SRX2513054 | 293 Kidney | 2633 / 15948 (16.5%) | 16995 / 159480 (10.7%) | −99.0 | −96.9 | 1.55 |
| 8-Hydroxydeoxyguanosine SRX13840523 | MCF 10A Breast | 1504 / 15948 (9.4%) | 8114 / 159480 (5.1%) | −98.7 | −96.7 | 1.85 |
| ESR1 SRX20282966 | MCF-7 Breast | 172 / 15948 (1.1%) | 6290 / 159480 (3.9%) | −98.7 | −96.7 | 0.27 |
| FOXA1 SRX100477 | Hep G2 Liver | 518 / 15948 (3.2%) | 11658 / 159480 (7.3%) | −98.4 | −96.3 | 0.44 |
| DTL SRX4107934 | U2OS Bone | 964 / 15948 (6.0%) | 4310 / 159480 (2.7%) | −98.1 | −96.1 | 2.24 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1172 / 15948 (7.3%) | 5734 / 159480 (3.6%) | −98.0 | −96.0 | 2.04 |
| ESR1 SRX3123830 | MCF-7 Breast | 140 / 15948 (0.9%) | 5691 / 159480 (3.6%) | −97.9 | −95.9 | 0.25 |
| ESR1 SRX2513519 | MCF-7 Breast | 263 / 15948 (1.6%) | 7789 / 159480 (4.9%) | −97.8 | −95.7 | 0.34 |
| FOXA1 SRX1787654 | MCF-7 Breast | 182 / 15948 (1.1%) | 6434 / 159480 (4.0%) | −97.7 | −95.6 | 0.28 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 401 / 15948 (2.5%) | 9921 / 159480 (6.2%) | −97.6 | −95.6 | 0.40 |
| NR2F2 SRX190293 | MCF-7 Breast | 488 / 15948 (3.1%) | 11190 / 159480 (7.0%) | −97.4 | −95.4 | 0.44 |
| FOXA1 SRX5323846 | MCF-7 Breast | 186 / 15948 (1.2%) | 6493 / 159480 (4.1%) | −97.4 | −95.3 | 0.29 |
| SSRP1 SRX3436564 | HT-1080 Bone | 427 / 15948 (2.7%) | 1127 / 159480 (0.7%) | −97.3 | −95.2 | 3.79 |
| ESR1 SRX5323872 | MCF-7 Breast | 458 / 15948 (2.9%) | 10745 / 159480 (6.7%) | −97.2 | −95.1 | 0.43 |
| ESR1 SRX792933 | LY2 Breast | 385 / 15948 (2.4%) | 9665 / 159480 (6.1%) | −97.2 | −95.1 | 0.40 |
| AR SRX1067070 | LHSAR Prostate | 1030 / 15948 (6.5%) | 18490 / 159480 (11.6%) | −97.1 | −95.1 | 0.56 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1650 / 15948 (10.3%) | 9256 / 159480 (5.8%) | −97.1 | −95.1 | 1.78 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1339 / 15948 (8.4%) | 6951 / 159480 (4.4%) | −97.0 | −95.0 | 1.93 |
| GFP SRX12567763 | MRC-5 Lung | 1391 / 15948 (8.7%) | 7338 / 159480 (4.6%) | −96.7 | −94.6 | 1.90 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 431 / 15948 (2.7%) | 10327 / 159480 (6.5%) | −96.6 | −94.5 | 0.42 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1228 / 15948 (7.7%) | 20961 / 159480 (13.1%) | −96.4 | −94.4 | 0.59 |
| FOXA1 SRX3931056 | MCF-7 Breast | 281 / 15948 (1.8%) | 8026 / 159480 (5.0%) | −96.3 | −94.2 | 0.35 |
| TFAP2C SRX018833 | MCF-7 Breast | 422 / 15948 (2.6%) | 10179 / 159480 (6.4%) | −96.2 | −94.1 | 0.41 |
| ESR1 SRX1012631 | MCF-7 Breast | 221 / 15948 (1.4%) | 7041 / 159480 (4.4%) | −95.9 | −93.9 | 0.31 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 882 / 15948 (5.5%) | 3813 / 159480 (2.4%) | −95.9 | −93.8 | 2.31 |
| ESR1 SRX8537719 | SUM 44PE Breast | 287 / 15948 (1.8%) | 8107 / 159480 (5.1%) | −95.8 | −93.8 | 0.35 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 379 / 15948 (2.4%) | 9517 / 159480 (6.0%) | −95.7 | −93.7 | 0.40 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1257 / 15948 (7.9%) | 6397 / 159480 (4.0%) | −95.6 | −93.6 | 1.96 |
| ESR1 SRX2513518 | MCF-7 Breast | 241 / 15948 (1.5%) | 7353 / 159480 (4.6%) | −95.5 | −93.5 | 0.33 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 184 / 15948 (1.2%) | 6395 / 159480 (4.0%) | −95.5 | −93.5 | 0.29 |
| ESR1 SRX968963 | MCF-7 Breast | 203 / 15948 (1.3%) | 6723 / 159480 (4.2%) | −95.5 | −93.5 | 0.30 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1442 / 15948 (9.0%) | 23556 / 159480 (14.8%) | −95.5 | −93.4 | 0.61 |
| ESR1 SRX5323878 | MCF-7 Breast | 467 / 15948 (2.9%) | 10799 / 159480 (6.8%) | −95.2 | −93.2 | 0.43 |
| TFAP2C SRX128099 | MCF-7 Breast | 423 / 15948 (2.7%) | 10153 / 159480 (6.4%) | −95.2 | −93.2 | 0.42 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 196 / 15948 (1.2%) | 6584 / 159480 (4.1%) | −94.9 | −92.9 | 0.30 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 410 / 15948 (2.6%) | 9946 / 159480 (6.2%) | −94.9 | −92.8 | 0.41 |
| ESR1 SRX5534831 | MCF-7 Breast | 374 / 15948 (2.3%) | 9390 / 159480 (5.9%) | −94.3 | −92.3 | 0.40 |
| JADE3 DRX300415 | 293 Kidney | 1235 / 15948 (7.7%) | 6277 / 159480 (3.9%) | −94.3 | −92.3 | 1.97 |
| FOXA1 SRX3931032 | MCF-7 Breast | 284 / 15948 (1.8%) | 7993 / 159480 (5.0%) | −94.0 | −92.0 | 0.36 |
| FOXA1 SRX3931033 | MCF-7 Breast | 310 / 15948 (1.9%) | 8401 / 159480 (5.3%) | −94.0 | −92.0 | 0.37 |
| ARID5B SRX3230377 | Hep G2 Liver | 1063 / 15948 (6.7%) | 18726 / 159480 (11.7%) | −93.5 | −91.4 | 0.57 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 275 / 15948 (1.7%) | 7829 / 159480 (4.9%) | −93.4 | −91.4 | 0.35 |
| ARID1A SRX5089379 | MCF-7 Breast | 478 / 15948 (3.0%) | 10876 / 159480 (6.8%) | −93.3 | −91.3 | 0.44 |
| MECOM SRX23677885 | HNT-34 Blood | 1429 / 15948 (9.0%) | 7719 / 159480 (4.8%) | −93.2 | −91.2 | 1.85 |
| AHR SRX20282969 | MCF-7 Breast | 232 / 15948 (1.5%) | 7126 / 159480 (4.5%) | −93.1 | −91.1 | 0.33 |
| JUN SRX4192884 | MCF 10A Breast | 412 / 15948 (2.6%) | 9901 / 159480 (6.2%) | −93.0 | −90.9 | 0.42 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 214 / 15948 (1.3%) | 6815 / 159480 (4.3%) | −92.9 | −90.9 | 0.31 |
| YAP1 SRX757325 | H2052 Lung | 1110 / 15948 (7.0%) | 19284 / 159480 (12.1%) | −92.8 | −90.8 | 0.58 |
| YAP1 SRX757326 | H2052 Lung | 955 / 15948 (6.0%) | 17301 / 159480 (10.8%) | −92.7 | −90.7 | 0.55 |
| NANOG SRX10445309 | Neural crest cells Neural | 270 / 15948 (1.7%) | 7716 / 159480 (4.8%) | −92.6 | −90.6 | 0.35 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1272 / 15948 (8.0%) | 6595 / 159480 (4.1%) | −92.3 | −90.3 | 1.93 |
| TET2 SRX8617003 | MCF-7 Breast | 171 / 15948 (1.1%) | 6064 / 159480 (3.8%) | −92.3 | −90.3 | 0.28 |
| AR SRX10365514 | MCF-7 Breast | 122 / 15948 (0.8%) | 5181 / 159480 (3.2%) | −92.3 | −90.3 | 0.24 |
| ESR1 SRX3080214 | MCF-7 Breast | 128 / 15948 (0.8%) | 5289 / 159480 (3.3%) | −92.2 | −90.3 | 0.24 |
| ESR1 SRX3080213 | MCF-7 Breast | 138 / 15948 (0.9%) | 5471 / 159480 (3.4%) | −92.1 | −90.1 | 0.25 |
| ESR1 SRX5287703 | MCF-7 Breast | 252 / 15948 (1.6%) | 7413 / 159480 (4.6%) | −92.1 | −90.1 | 0.34 |
| FOXA1 SRX5323829 | T-47D Breast | 280 / 15948 (1.8%) | 7855 / 159480 (4.9%) | −92.0 | −90.0 | 0.36 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 416 / 15948 (2.6%) | 9921 / 159480 (6.2%) | −92.0 | −90.0 | 0.42 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 172 / 15948 (1.1%) | 6067 / 159480 (3.8%) | −91.8 | −89.8 | 0.28 |
| ESR1 SRX1469950 | MCF-7 Breast | 191 / 15948 (1.2%) | 6389 / 159480 (4.0%) | −91.6 | −89.6 | 0.30 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 441 / 15948 (2.8%) | 1258 / 159480 (0.8%) | −91.6 | −89.6 | 3.51 |
| SSRP1 SRX3436565 | HT-1080 Bone | 361 / 15948 (2.3%) | 864 / 159480 (0.5%) | −91.6 | −89.6 | 4.18 |
| ESR1 SRX8537718 | SUM 44PE Breast | 287 / 15948 (1.8%) | 7945 / 159480 (5.0%) | −91.5 | −89.5 | 0.36 |
| NABP2 SRX9523535 | HT-1080 Bone | 1125 / 15948 (7.1%) | 5568 / 159480 (3.5%) | −91.4 | −89.5 | 2.02 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1389 / 15948 (8.7%) | 7475 / 159480 (4.7%) | −91.4 | −89.4 | 1.86 |
| HMG20A SRX2630163 | Hep G2 Liver | 286 / 15948 (1.8%) | 7919 / 159480 (5.0%) | −91.2 | −89.2 | 0.36 |
| SKP2 SRX4107930 | HCT 116 Digestive tract | 943 / 15948 (5.9%) | 4318 / 159480 (2.7%) | −91.2 | −89.2 | 2.18 |
| ARID5B SRX10475139 | Hep G2 Liver | 513 / 15948 (3.2%) | 11285 / 159480 (7.1%) | −91.1 | −89.2 | 0.45 |
| ESR1 SRX5323874 | MCF-7 Breast | 298 / 15948 (1.9%) | 8093 / 159480 (5.1%) | −90.8 | −88.8 | 0.37 |
| TET2 SRX8617001 | MCF-7 Breast | 328 / 15948 (2.1%) | 8550 / 159480 (5.4%) | −90.6 | −88.6 | 0.38 |
| ESR1 SRX5089447 | MCF-7 Breast | 240 / 15948 (1.5%) | 7156 / 159480 (4.5%) | −90.4 | −88.4 | 0.34 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1493 / 15948 (9.4%) | 8283 / 159480 (5.2%) | −90.3 | −88.4 | 1.80 |
| SSRP1 SRX3436566 | HT-1080 Bone | 232 / 15948 (1.5%) | 338 / 159480 (0.2%) | −90.2 | −88.2 | 6.86 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 448 / 15948 (2.8%) | 1310 / 159480 (0.8%) | −90.2 | −88.2 | 3.42 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1125 / 15948 (7.1%) | 19337 / 159480 (12.1%) | −90.1 | −88.1 | 0.58 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 332 / 15948 (2.1%) | 8577 / 159480 (5.4%) | −89.7 | −87.8 | 0.39 |
| FOXA2 SRX10475773 | Hep G2 Liver | 564 / 15948 (3.5%) | 11939 / 159480 (7.5%) | −89.6 | −87.6 | 0.47 |
| AR SRX9109113 | MDA-MB-453 Breast | 856 / 15948 (5.4%) | 15864 / 159480 (9.9%) | −89.5 | −87.6 | 0.54 |
| TEAD1 SRX3401272 | MCF-7 Breast | 382 / 15948 (2.4%) | 9323 / 159480 (5.8%) | −89.5 | −87.5 | 0.41 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 316 / 15948 (2.0%) | 8320 / 159480 (5.2%) | −89.4 | −87.4 | 0.38 |
| STAT1 SRX23678708 | K-562 Blood | 1227 / 15948 (7.7%) | 6350 / 159480 (4.0%) | −89.3 | −87.4 | 1.93 |
| 5-hmC SRX19636323 | HMLE Breast | 1134 / 15948 (7.1%) | 5686 / 159480 (3.6%) | −89.2 | −87.2 | 1.99 |
| PROX1 SRX3230397 | Hep G2 Liver | 361 / 15948 (2.3%) | 8984 / 159480 (5.6%) | −88.9 | −87.0 | 0.40 |
| CXXC1 SRX1424886 | SEM Blood | 1169 / 15948 (7.3%) | 5946 / 159480 (3.7%) | −88.9 | −86.9 | 1.97 |
| ESR1 SRX20282967 | MCF-7 Breast | 163 / 15948 (1.0%) | 5813 / 159480 (3.6%) | −88.9 | −86.9 | 0.28 |
| CBX3 SRX6712570 | MCF-7 Breast | 390 / 15948 (2.4%) | 9411 / 159480 (5.9%) | −88.8 | −86.8 | 0.41 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 985 / 15948 (6.2%) | 4656 / 159480 (2.9%) | −88.8 | −86.8 | 2.12 |
| ESR1 SRX176858 | MCF-7 Breast | 187 / 15948 (1.2%) | 6218 / 159480 (3.9%) | −88.6 | −86.7 | 0.30 |
| SKP2 SRX4107932 | HCT 116 Digestive tract | 1015 / 15948 (6.4%) | 4868 / 159480 (3.1%) | −88.6 | −86.6 | 2.09 |
| FOXA1 SRX5323844 | MCF-7 Breast | 152 / 15948 (1.0%) | 5611 / 159480 (3.5%) | −88.5 | −86.6 | 0.27 |
| NR3C1 SRX8520802 | HCC1187 Breast | 369 / 15948 (2.3%) | 9089 / 159480 (5.7%) | −88.4 | −86.5 | 0.41 |
| NCOA3 SRX10365550 | MCF-7 Breast | 58 / 15948 (0.4%) | 3781 / 159480 (2.4%) | −88.4 | −86.5 | 0.15 |
| FOXA1 SRX15430999 | T-47D Breast | 524 / 15948 (3.3%) | 11319 / 159480 (7.1%) | −88.3 | −86.3 | 0.46 |
| SREBF2 SRX5359048 | HCC70 Breast | 1347 / 15948 (8.4%) | 7259 / 159480 (4.6%) | −88.2 | −86.3 | 1.86 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 137 / 15948 (0.9%) | 73 / 159480 (0.0%) | −88.2 | −86.3 | 18.77 |
| FOXA1 SRX3923510 | MCF-7 Breast | 201 / 15948 (1.3%) | 6439 / 159480 (4.0%) | −88.2 | −86.2 | 0.31 |
| JADE3 DRX234809 | 293 Kidney | 806 / 15948 (5.1%) | 3473 / 159480 (2.2%) | −88.1 | −86.1 | 2.32 |
| ESR1 SRX20282945 | MCF-7 Breast | 141 / 15948 (0.9%) | 5396 / 159480 (3.4%) | −88.0 | −86.1 | 0.26 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 234 / 15948 (1.5%) | 6973 / 159480 (4.4%) | −87.9 | −86.0 | 0.34 |
| SOX13 SRX2636248 | Hep G2 Liver | 643 / 15948 (4.0%) | 12949 / 159480 (8.1%) | −87.9 | −86.0 | 0.50 |
| ESR1 SRX3123810 | MCF-7 Breast | 122 / 15948 (0.8%) | 5044 / 159480 (3.2%) | −87.9 | −85.9 | 0.24 |
| ERG SRX063922 | K-562 Blood | 1260 / 15948 (7.9%) | 6632 / 159480 (4.2%) | −87.8 | −85.9 | 1.90 |
| FOXA1 SRX5323850 | MCF-7 Breast | 138 / 15948 (0.9%) | 5336 / 159480 (3.3%) | −87.8 | −85.8 | 0.26 |
| MCM2 SRX12221319 | HCT 116 Digestive tract | 323 / 15948 (2.0%) | 723 / 159480 (0.5%) | −87.7 | −85.8 | 4.47 |
| FOXA1 SRX3923513 | MCF-7 Breast | 168 / 15948 (1.1%) | 5860 / 159480 (3.7%) | −87.7 | −85.7 | 0.29 |
| FOXA1 SRX3931073 | MCF-7 Breast | 303 / 15948 (1.9%) | 8054 / 159480 (5.1%) | −87.7 | −85.7 | 0.38 |
| GATAD2A SRX2636506 | Hep G2 Liver | 605 / 15948 (3.8%) | 12420 / 159480 (7.8%) | −87.6 | −85.7 | 0.49 |
| ERG SRX063921 | K-562 Blood | 1199 / 15948 (7.5%) | 6194 / 159480 (3.9%) | −87.6 | −85.7 | 1.94 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 329 / 15948 (2.1%) | 8444 / 159480 (5.3%) | −87.5 | −85.5 | 0.39 |
| XPO1 SRX14127501 | OCI-AML3 Blood | 393 / 15948 (2.5%) | 1059 / 159480 (0.7%) | −87.4 | −85.5 | 3.71 |
| MCM2 SRX12221314 | HCT 116 Digestive tract | 329 / 15948 (2.1%) | 753 / 159480 (0.5%) | −87.4 | −85.5 | 4.37 |
| ESR1 SRX176857 | MCF-7 Breast | 186 / 15948 (1.2%) | 6155 / 159480 (3.9%) | −87.3 | −85.3 | 0.30 |
| FOXA1 SRX8537737 | MCF-7 Breast | 206 / 15948 (1.3%) | 6490 / 159480 (4.1%) | −87.3 | −85.3 | 0.32 |
| BrdU SRX3758833 | HeLa Uterus | 393 / 15948 (2.5%) | 1061 / 159480 (0.7%) | −87.2 | −85.3 | 3.70 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 264 / 15948 (1.7%) | 7423 / 159480 (4.7%) | −87.0 | −85.1 | 0.36 |
| PGR SRX1012654 | MCF-7 Breast | 195 / 15948 (1.2%) | 6298 / 159480 (3.9%) | −87.0 | −85.1 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 334 / 15948 (2.1%) | 8501 / 159480 (5.3%) | −86.9 | −85.0 | 0.39 |
| ESR1 SRX1585242 | MCF-7 Breast | 201 / 15948 (1.3%) | 6388 / 159480 (4.0%) | −86.7 | −84.8 | 0.31 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 259 / 15948 (1.6%) | 7329 / 159480 (4.6%) | −86.6 | −84.7 | 0.35 |
| FOXA1 SRX1033292 | LNCAP Prostate | 266 / 15948 (1.7%) | 7441 / 159480 (4.7%) | −86.6 | −84.7 | 0.36 |
| FOXA1 SRX8537736 | MCF-7 Breast | 193 / 15948 (1.2%) | 6249 / 159480 (3.9%) | −86.5 | −84.6 | 0.31 |
| AR SRX17042314 | VCaP Prostate | 343 / 15948 (2.2%) | 8617 / 159480 (5.4%) | −86.4 | −84.5 | 0.40 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 339 / 15948 (2.1%) | 8556 / 159480 (5.4%) | −86.3 | −84.4 | 0.40 |
| FOXA1 SRX5203311 | MCF-7 Breast | 98 / 15948 (0.6%) | 4538 / 159480 (2.8%) | −86.3 | −84.4 | 0.22 |
| ESR1 SRX5323876 | MCF-7 Breast | 277 / 15948 (1.7%) | 7595 / 159480 (4.8%) | −86.2 | −84.3 | 0.36 |
| EP300 SRX1012649 | MCF-7 Breast | 178 / 15948 (1.1%) | 5974 / 159480 (3.7%) | −85.9 | −84.0 | 0.30 |
| FOS SRX150476 | MCF 10A Breast | 815 / 15948 (5.1%) | 15143 / 159480 (9.5%) | −85.8 | −83.9 | 0.54 |
| FOXA1 SRX1161207 | T-47D Breast | 222 / 15948 (1.4%) | 6700 / 159480 (4.2%) | −85.7 | −83.8 | 0.33 |
| FOXA1 SRX142908 | LNCAP Prostate | 269 / 15948 (1.7%) | 7452 / 159480 (4.7%) | −85.7 | −83.8 | 0.36 |
| FOXA1 SRX6878603 | LNCAP Prostate | 530 / 15948 (3.3%) | 11292 / 159480 (7.1%) | −85.7 | −83.8 | 0.47 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1265 / 15948 (7.9%) | 6730 / 159480 (4.2%) | −85.6 | −83.7 | 1.88 |
| GATAD2A SRX2636507 | Hep G2 Liver | 524 / 15948 (3.3%) | 11203 / 159480 (7.0%) | −85.6 | −83.7 | 0.47 |
| NCOA3 SRX10365548 | MCF-7 Breast | 94 / 15948 (0.6%) | 4437 / 159480 (2.8%) | −85.5 | −83.6 | 0.21 |
| INTS3 SRX3640569 | HeLa Uterus | 1014 / 15948 (6.4%) | 4939 / 159480 (3.1%) | −85.3 | −83.4 | 2.05 |
| RBFOX2 SRX4708082 | K-562 Blood | 1929 / 15948 (12.1%) | 11842 / 159480 (7.4%) | −85.2 | −83.3 | 1.63 |
| FOXA2 SRX10475774 | Hep G2 Liver | 236 / 15948 (1.5%) | 6905 / 159480 (4.3%) | −85.1 | −83.2 | 0.34 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 277 / 15948 (1.7%) | 545 / 159480 (0.3%) | −85.0 | −83.1 | 5.08 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1384 / 15948 (8.7%) | 7632 / 159480 (4.8%) | −84.9 | −83.0 | 1.81 |
| ARID1A SRX5089388 | MCF-7 Breast | 276 / 15948 (1.7%) | 7527 / 159480 (4.7%) | −84.8 | −82.9 | 0.37 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1244 / 15948 (7.8%) | 6600 / 159480 (4.1%) | −84.8 | −82.9 | 1.88 |
| ESR1 SRX2922232 | SUM 44PE Breast | 226 / 15948 (1.4%) | 6732 / 159480 (4.2%) | −84.7 | −82.8 | 0.34 |
| FOXA1 SRX1161203 | T-47D Breast | 365 / 15948 (2.3%) | 8883 / 159480 (5.6%) | −84.7 | −82.8 | 0.41 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 608 / 15948 (3.8%) | 12330 / 159480 (7.7%) | −84.7 | −82.8 | 0.49 |
| FOXA1 SRX3923509 | MCF-7 Breast | 163 / 15948 (1.0%) | 5675 / 159480 (3.6%) | −84.7 | −82.8 | 0.29 |
| ARID1A SRX5089391 | MCF-7 Breast | 301 / 15948 (1.9%) | 7911 / 159480 (5.0%) | −84.6 | −82.7 | 0.38 |
| ESR1 SRX9719167 | MCF-7 Breast | 244 / 15948 (1.5%) | 7015 / 159480 (4.4%) | −84.5 | −82.6 | 0.35 |
| SETD1A SRX23734379 | MOLM-13 Blood | 974 / 15948 (6.1%) | 4689 / 159480 (2.9%) | −84.2 | −82.3 | 2.08 |
| GATA3 SRX5457550 | MCF-7 Breast | 551 / 15948 (3.5%) | 11519 / 159480 (7.2%) | −84.2 | −82.3 | 0.48 |
| GATA3 SRX6712580 | MCF-7 Breast | 161 / 15948 (1.0%) | 5620 / 159480 (3.5%) | −84.1 | −82.2 | 0.29 |
| AR SRX1067066 | LHSAR Prostate | 942 / 15948 (5.9%) | 16688 / 159480 (10.5%) | −83.8 | −81.9 | 0.56 |
| SAP30 SRX17989898 | MDA-MB-231 Breast | 1240 / 15948 (7.8%) | 6600 / 159480 (4.1%) | −83.7 | −81.8 | 1.88 |
| NFIL3 SRX2630334 | Hep G2 Liver | 404 / 15948 (2.5%) | 9416 / 159480 (5.9%) | −83.7 | −81.8 | 0.43 |
| FOXA1 SRX3923508 | MCF-7 Breast | 178 / 15948 (1.1%) | 5894 / 159480 (3.7%) | −83.6 | −81.7 | 0.30 |
| ESR1 SRX5089450 | MCF-7 Breast | 287 / 15948 (1.8%) | 7647 / 159480 (4.8%) | −83.4 | −81.5 | 0.38 |
| ESR1 SRX5323875 | MCF-7 Breast | 206 / 15948 (1.3%) | 6356 / 159480 (4.0%) | −83.4 | −81.5 | 0.32 |
| FOXA1 SRX747794 | MCF-7 Breast | 71 / 15948 (0.4%) | 3911 / 159480 (2.5%) | −83.3 | −81.4 | 0.18 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 423 / 15948 (2.7%) | 9668 / 159480 (6.1%) | −83.2 | −81.3 | 0.44 |
| AR SRX15946405 | MDA-MB-453 Breast | 336 / 15948 (2.1%) | 8382 / 159480 (5.3%) | −83.1 | −81.2 | 0.40 |
| ESR1 SRX20282944 | MCF-7 Breast | 103 / 15948 (0.6%) | 4534 / 159480 (2.8%) | −83.0 | −81.1 | 0.23 |
| TRPS1 SRX3401273 | MCF-7 Breast | 193 / 15948 (1.2%) | 6125 / 159480 (3.8%) | −82.8 | −81.0 | 0.32 |
| EP300 SRX176884 | MCF-7 Breast | 126 / 15948 (0.8%) | 4956 / 159480 (3.1%) | −82.8 | −81.0 | 0.25 |
| FOXA1 SRX3931031 | MCF-7 Breast | 256 / 15948 (1.6%) | 7142 / 159480 (4.5%) | −82.8 | −80.9 | 0.36 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1535 / 15948 (9.6%) | 8848 / 159480 (5.5%) | −82.7 | −80.8 | 1.73 |
| KMT2B DRX059614 | HB1119 Blood | 688 / 15948 (4.3%) | 2823 / 159480 (1.8%) | −82.4 | −80.5 | 2.44 |
| ZFX SRX7805370 | 293 Kidney | 906 / 15948 (5.7%) | 4263 / 159480 (2.7%) | −82.3 | −80.5 | 2.13 |
| FOXA1 SRX10024492 | MCF-7 Breast | 123 / 15948 (0.8%) | 4886 / 159480 (3.1%) | −82.3 | −80.4 | 0.25 |
| ESR1 SRX3123817 | MCF-7 Breast | 84 / 15948 (0.5%) | 4145 / 159480 (2.6%) | −82.2 | −80.4 | 0.20 |
| FOXA1 SRX2642368 | VCaP Prostate | 582 / 15948 (3.6%) | 11861 / 159480 (7.4%) | −82.2 | −80.3 | 0.49 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 632 / 15948 (4.0%) | 12537 / 159480 (7.9%) | −82.1 | −80.2 | 0.50 |
| ARID1A SRX5089385 | MCF-7 Breast | 395 / 15948 (2.5%) | 9219 / 159480 (5.8%) | −82.1 | −80.2 | 0.43 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1278 / 15948 (8.0%) | 6930 / 159480 (4.3%) | −82.1 | −80.2 | 1.84 |
| FOS SRX150517 | MCF 10A Breast | 822 / 15948 (5.2%) | 15054 / 159480 (9.4%) | −82.1 | −80.2 | 0.55 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 970 / 15948 (6.1%) | 4714 / 159480 (3.0%) | −82.0 | −80.1 | 2.06 |
| KDM6A SRX15826236 | MCF-7 Breast | 188 / 15948 (1.2%) | 6005 / 159480 (3.8%) | −81.9 | −80.0 | 0.31 |
| MECOM SRX23677884 | HNT-34 Blood | 1369 / 15948 (8.6%) | 7612 / 159480 (4.8%) | −81.9 | −80.0 | 1.80 |
| FOXA1 SRX3923512 | MCF-7 Breast | 163 / 15948 (1.0%) | 5584 / 159480 (3.5%) | −81.9 | −80.0 | 0.29 |
| MECOM SRX23677896 | HNT-34 Blood | 1705 / 15948 (10.7%) | 10195 / 159480 (6.4%) | −81.9 | −80.0 | 1.67 |
| EP300 SRX1012647 | MCF-7 Breast | 217 / 15948 (1.4%) | 6482 / 159480 (4.1%) | −81.8 | −80.0 | 0.33 |
| FOXA3 SRX2630190 | Hep G2 Liver | 428 / 15948 (2.7%) | 9686 / 159480 (6.1%) | −81.8 | −80.0 | 0.44 |
| AR SRX11149848 | MDA-MB-453 Breast | 340 / 15948 (2.1%) | 8387 / 159480 (5.3%) | −81.7 | −79.8 | 0.41 |
| NR3C1 SRX19024868 | MCF-7 Breast | 98 / 15948 (0.6%) | 4401 / 159480 (2.8%) | −81.7 | −79.8 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 534 / 15948 (3.3%) | 11175 / 159480 (7.0%) | −81.7 | −79.8 | 0.48 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 1243 / 15948 (7.8%) | 6688 / 159480 (4.2%) | −81.4 | −79.6 | 1.86 |
| FOXA1 SRX1961158 | T-47D Breast | 491 / 15948 (3.1%) | 10561 / 159480 (6.6%) | −81.4 | −79.5 | 0.46 |
| Epitope tags SRX2867680 | 293 Kidney | 1683 / 15948 (10.6%) | 10043 / 159480 (6.3%) | −81.3 | −79.4 | 1.68 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 575 / 15948 (3.6%) | 11725 / 159480 (7.4%) | −81.3 | −79.4 | 0.49 |
| FOXA1 SRX5323830 | T-47D Breast | 316 / 15948 (2.0%) | 8013 / 159480 (5.0%) | −81.3 | −79.4 | 0.39 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 574 / 15948 (3.6%) | 11708 / 159480 (7.3%) | −81.3 | −79.4 | 0.49 |
| SAP30 SRX17989897 | MDA-MB-231 Breast | 1541 / 15948 (9.7%) | 8944 / 159480 (5.6%) | −81.2 | −79.3 | 1.72 |
| ZEB1 SRX13298923 | MCF-7 Breast | 237 / 15948 (1.5%) | 6780 / 159480 (4.3%) | −81.1 | −79.2 | 0.35 |
| JUNB SRX4192882 | MCF 10A Breast | 425 / 15948 (2.7%) | 9610 / 159480 (6.0%) | −81.1 | −79.2 | 0.44 |
| RBM22 SRX4708083 | K-562 Blood | 725 / 15948 (4.5%) | 3085 / 159480 (1.9%) | −81.0 | −79.2 | 2.35 |
| Epitope tags SRX8080552 | Mammary gland ductal carcinoma Breast | 267 / 15948 (1.7%) | 7248 / 159480 (4.5%) | −81.0 | −79.1 | 0.37 |
| FOXM1 SRX185907 | MCF-7 Breast | 123 / 15948 (0.8%) | 4842 / 159480 (3.0%) | −80.9 | −79.0 | 0.25 |
| FOXA1 SRX497612 | VCaP Prostate | 471 / 15948 (3.0%) | 10251 / 159480 (6.4%) | −80.8 | −78.9 | 0.46 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 508 / 15948 (3.2%) | 10771 / 159480 (6.8%) | −80.7 | −78.8 | 0.47 |
| STAT1 SRX23678707 | K-562 Blood | 1119 / 15948 (7.0%) | 5806 / 159480 (3.6%) | −80.7 | −78.8 | 1.93 |
| NR3C1 SRX1161167 | MCF-7 Breast | 160 / 15948 (1.0%) | 5488 / 159480 (3.4%) | −80.6 | −78.8 | 0.29 |
| ESR1 SRX2881004 | MCF-7 Breast | 155 / 15948 (1.0%) | 5398 / 159480 (3.4%) | −80.6 | −78.7 | 0.29 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1527 / 15948 (9.6%) | 8857 / 159480 (5.6%) | −80.6 | −78.7 | 1.72 |
| KMT2B DRX059615 | HB1119 Blood | 688 / 15948 (4.3%) | 2862 / 159480 (1.8%) | −80.4 | −78.5 | 2.40 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 349 / 15948 (2.2%) | 8468 / 159480 (5.3%) | −80.3 | −78.4 | 0.41 |
| PGR SRX1012659 | MCF-7 Breast | 158 / 15948 (1.0%) | 5437 / 159480 (3.4%) | −80.2 | −78.3 | 0.29 |
| CDK9 SRX7366779 | MCF-7 Breast | 149 / 15948 (0.9%) | 124 / 159480 (0.1%) | −80.1 | −78.3 | 12.02 |
| ESR1 SRX1161171 | MCF-7 Breast | 98 / 15948 (0.6%) | 4347 / 159480 (2.7%) | −79.9 | −78.1 | 0.23 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 417 / 15948 (2.6%) | 1267 / 159480 (0.8%) | −79.9 | −78.1 | 3.29 |
| Epitope tags SRX10549777 | K-562 Blood | 1976 / 15948 (12.4%) | 12430 / 159480 (7.8%) | −79.8 | −78.0 | 1.59 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 451 / 15948 (2.8%) | 9930 / 159480 (6.2%) | −79.8 | −78.0 | 0.45 |
| GATA3 SRX100559 | T-47D Breast | 551 / 15948 (3.5%) | 11324 / 159480 (7.1%) | −79.8 | −77.9 | 0.49 |
| RAD21 SRX3482875 | hESC HUES64 Pluripotent stem cell | 739 / 15948 (4.6%) | 13847 / 159480 (8.7%) | −79.7 | −77.9 | 0.53 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1422 / 15948 (8.9%) | 8086 / 159480 (5.1%) | −79.7 | −77.8 | 1.76 |
| ZEB1 SRX13298925 | MCF-7 Breast | 338 / 15948 (2.1%) | 8276 / 159480 (5.2%) | −79.6 | −77.8 | 0.41 |
| EP300 SRX1012642 | MCF-7 Breast | 70 / 15948 (0.4%) | 3782 / 159480 (2.4%) | −79.6 | −77.7 | 0.19 |
| 5-mC SRX882970 | LNCAP Prostate | 2247 / 15948 (14.1%) | 14653 / 159480 (9.2%) | −79.6 | −77.7 | 1.53 |
| NR3C1 SRX19024880 | MCF-7 Breast | 161 / 15948 (1.0%) | 5468 / 159480 (3.4%) | −79.5 | −77.7 | 0.29 |
| ESR1 SRX3123828 | MCF-7 Breast | 97 / 15948 (0.6%) | 4313 / 159480 (2.7%) | −79.4 | −77.6 | 0.22 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1322 / 15948 (8.3%) | 7340 / 159480 (4.6%) | −79.3 | −77.5 | 1.80 |
| FOXA1 SRX10024494 | MCF-7 Breast | 112 / 15948 (0.7%) | 4593 / 159480 (2.9%) | −79.3 | −77.5 | 0.24 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 396 / 15948 (2.5%) | 9118 / 159480 (5.7%) | −79.3 | −77.5 | 0.43 |
| ZFX SRX7805372 | 293 Kidney | 1230 / 15948 (7.7%) | 6656 / 159480 (4.2%) | −79.3 | −77.5 | 1.85 |
| CEBPA SRX2630242 | Hep G2 Liver | 272 / 15948 (1.7%) | 7256 / 159480 (4.5%) | −79.1 | −77.3 | 0.37 |
| ZEB1 SRX13298924 | MCF-7 Breast | 275 / 15948 (1.7%) | 7299 / 159480 (4.6%) | −79.0 | −77.2 | 0.38 |
Showing first 500 of 20930 rows.